"The U.S. Food and Drug Administration today approved Liposorber LA-15 System to treat pediatric patients with primary focal segmental glomerulosclerosis (FSGS) either before transplant, or after renal (kidney) transplantation in which there is re"...
- Clinician Information:
Normocarb HF Side Effects Center
Medical Editor: John Cunha, DO, FACOEP
Normocarb HF (sodium chloride/magnesium chloride hexahydrate/sodium bicarbonate) is used for adults and children for Continuous Renal Replacement Therapy (CRRT) as a replacement solution in hemofiltration or hemodiafiltration. Side effects can result for the solution of the CRRT procedure. Improper use can lead to fluid imbalance and disturbances in electrolyte, acid-base and glucose balance.
Normocarb is administered in a clinical setting and a physician determines dose. Normocarb may interact with filterable/dialyzable drugs, cardiac glycoside medications, or citrates. Tell your doctor all medications you use. There is no data available concerning use of Normocarb HF in pregnancy and/or breastfeeding.
Our Normocarb HF Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Normocarb HF FDA Prescribing Information: Side Effects
No information provided.
Read the entire FDA prescribing information for Normocarb HF (Sterile Electrolyte Concentrate for Infusion) »
Additional Normocarb HF Information
Report Problems to the Food and Drug Administration
Find out what women really need.